Pharma stocks gain, as Trump's tariff move actually could be a win for the sector

Core Insights - Pharmaceutical stocks experienced an overall gain on Friday, indicating a positive market reaction to recent developments in the sector [1] Group 1: Market Reaction - Traders appeared to shrug off or even cheer President Donald Trump's new tariff plan for drugmakers, suggesting a favorable sentiment towards the pharmaceutical industry despite potential regulatory changes [1]